Chondrosarcoma: Multi-Targeting Therapeutic Effects of Doxorubicin, BEZ235, and the Small Molecule Aspartyl-Asparaginyl-β-hydroxylase Inhibitor SMI1182.

Cancers (Basel) · 2025 · PMC12109828 · PMID 40427168

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

For example, the increased Humbug expression in CDS11 cells may be significant in relation to its Ca2+ binding effects in the ER [ 85 ].

also in 8,502 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.